Overexpression of oncogenic iASPP (inhibitory Apoptosis Stimulating Protein of TP53) is involved in therapy resistance and inferior outcome in triple negative breast cancer (TNBC)
- Resource Type
- Journal
- Source
ONCOLOGY RESEARCH AND TREATMENT ; OCT 2020, 43 SUPPL 4, p159-p159, 1p. Supplement: 4- Subject
- Language
- English
- ISSN
- 22965262